[Pharmacological studies of fusaric acid. II. (author's transl)].
作者信息
Matsuzaki M, Onodera K, Nakajima A, Kamei E, Koshino M
出版信息
Jpn J Antibiot. 1976 Apr;29(4):419-29.
PMID:819677
Abstract
摘要
相似文献
1
[Pharmacological studies of fusaric acid. II. (author's transl)].
Jpn J Antibiot. 1976 Apr;29(4):419-29.
2
[Pharmacological studies of fusaric acid. I. (author's transl)].
Jpn J Antibiot. 1976 Apr;29(4):403-18.
3
[Pharmacological studies of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone (M73101). (3). General pharmacological actions (author's transl)].4-乙氧基-2-甲基-5-吗啉基-3(2H)-哒嗪酮（M73101）的药理学研究。(3). 一般药理作用（作者译）
Nihon Yakurigaku Zasshi. 1979 Apr 20;75(3):291-307. doi: 10.1254/fpj.75.291.
4
Pharmacological action of FD-008, a new dopamine beta-hydroxylase inhibitor. I. Effects on blood pressure in rats and dogs.
Arzneimittelforschung. 1975 Jan;25(1):55-9.
5
[Effects of fusaric acid and its derivative on the cardiovascular system].
Nihon Yakurigaku Zasshi. 1976 Mar;72(2):139-44. doi: 10.1254/fpj.72.139.
6
[Fundamental studies on fusaric acid and calcium fusarate. Acute toxicity and antihypertensive effects (author's transl)].
Jpn J Antibiot. 1976 May;29(5):439-55.
7
Effects of fusaric acid on the membrane potential in left ventricle fragments from rats and rabbits.
Pharmazie. 1982 Oct;37(10):736.
8
Tachycardia in spontaneously hypertensive and normotensive rats after fusaric acid and bupicamide.
Clin Exp Pharmacol Physiol. 1976 May-Jun;3(3):199-206. doi: 10.1111/j.1440-1681.1976.tb02665.x.
9
Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
J Pharmacol Exp Ther. 1976 Sep;198(3):589-95.
10
Hypotensive action of N-ethoxycarbonyl3-morpholinosydnonimine, SIN-10.
Jpn J Pharmacol. 1970 Mar;20(1):102-15. doi: 10.1254/jjp.20.102.
Zotero 插件